Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions

Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions

Signaling pathway between human leukocyte antigen (HLA)-G and immune inhibitory receptors immunoglobulin-like transcript (ILT)-2/4 has been acknowledged as one of immune checkpoints, and as a potential target for cancer immunotherapy. Like other immune checkpoints, inter- and even intratumor heterog...

Full description

Bibliographic Details
Main Authors:	Xia Zhang, Aifen Lin, Qiu-Yue Han, Jian-Gang Zhang, Qiong-Yuan Chen, Yao-Han Ye, Wen-Jun Zhou, Hui-Hui Xu, Jun Gan, Wei-Hua Yan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-11-01
Series:	Frontiers in Immunology
Subjects:	HLA-G tumor heterogeneity isoform antibody colorectal cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2020.565759/full

Similar Items

Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
by: Aifen Lin, et al.
Published: (2018-09-01)

Structural Modeling and Molecular Dynamics of the Immune Checkpoint Molecule HLA-G
by: Thais Arns, et al.
Published: (2020-11-01)

Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer
by: Qiong-Yuan Chen, et al.
Published: (2021-05-01)

HLA-G 3’UTR polymorphism diplotypes and soluble HLA-G plasma levels impact cervical cancer susceptibility and prognosis
by: Jun Gan, et al.
Published: (2022-12-01)

Low Prevalence of HLA-G Antibodies in Lung Transplant Patients Detected using MAIPA-Adapted Protocol
by: Pascal Pedini, et al.
Published: (2023-11-01)

Prognostic significance of HLA-G in patients with colorectal cancer: a meta-analysis and bioinformatics analysis
by: Yingying Zhang, et al.
Published: (2023-10-01)

Diversity in the HLA-I Recognition of HLA-F Monoclonal Antibodies: HLA-F or HLA-Ib Monospecific, HLA-E or HLA-G Bispecific Antibodies with or without HLA-Ia Reactivity
by: Mepur H. Ravindranath, et al.
Published: (2024-01-01)

Intercellular transfer of HLA‐G: its potential in cancer immunology
by: Aifen Lin, et al.
Published: (2019-01-01)

Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions
by: Raylane P Gomes, et al.
Published: (2020-05-01)

Antibodies for β2-Microglobulin and the Heavy Chains of HLA-E, HLA-F, and HLA-G Reflect the HLA-Variants on Activated Immune Cells and Phases of Disease Progression in Rheumatoid Arthritis Patients under Treatment
by: Mepur H. Ravindranath, et al.
Published: (2023-03-01)

sHLA-G as a biomarker for colorectal cancer pathogenesis
by: Sabrine Dhouioui, et al.
Published: (2022-01-01)

HLA-G5 and G7 Isoforms in Pregnant Women
by: Saeid Abediankenari, et al.
Published: (2015-04-01)

HLA-G in Allergy: Does It Play an Immunoregulatory Role?
by: Simone Negrini, et al.
Published: (2022-01-01)

Interactions between HLA-G and HLA-E in physiological and pathological conditions
by: Fabio eMorandi, et al.
Published: (2014-08-01)

Meta-analysis of HLA-G 14bp insertion/deletion polymorphism and soluble HLA-G revealed an association with digestive cancers initiation and prognosis
by: Sabrine Dhouioui, et al.
Published: (2022-07-01)

HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
by: Aifen Lin, et al.
Published: (2021-06-01)

Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4
by: Nathalie Rouas-Freiss, et al.
Published: (2017-09-01)

HLA-G Expression in Lung Adenocarcinoma Tissues and Its Relationship with Prognosis
by: ZHANG Wenlong, et al.
Published: (2018-08-01)

The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
by: Jiji V. D. Attia, et al.
Published: (2020-11-01)

Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection
by: Aifen Lin, et al.
Published: (2021-12-01)

Impact of HLA-G in the outcome of vitiligo in Tunisian patients
by: Jalel Akrem, et al.
Published: (2010-01-01)

The Association of HLA-G Gene Polymorphism and Its Soluble Form With Male Infertility
by: Karolina Piekarska, et al.
Published: (2022-01-01)

Dynamics of peripheral immune cells and their HLA‐G and receptor expressions in a patient suffering from critical COVID‐19 pneumonia to convalescence
by: Sheng Zhang, et al.
Published: (2020-01-01)

Systematic Evaluation of HLA-G 3’Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients: UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease Outcome
by: Vera Rebmann, et al.
Published: (2022-01-01)

<i>HLA-G</i> Gene Variability Is Associated with Papillary Thyroid Carcinoma Morbidity and the HLA-G Protein Profile
by: Bruna C. Bertol, et al.
Published: (2023-08-01)

Expression of the Non-classical HLA-E, -F, -G Molecules in the Tumour Microenvironment
by: Ormandjieva Anastasia
Published: (2023-08-01)

HLA-G molecules in autoimmune diseases and infections
by: Roberta eRizzo, et al.
Published: (2014-11-01)

The role of maternal HLA-DR and HLA-G loci in determining the risk of sporadic congenital heart defects in the next generation
by: N. S. Deeva, et al.
Published: (2021-12-01)

HLA-G Expression Pattern: Reliable Assessment for Pregnancy Outcome Prediction
by: Elnaz Mosaferi, et al.
Published: (2013-08-01)

Association of <i>HLA-G</i> 3′UTR Polymorphisms with Response to First-Line FOLFIRI Treatment in Metastatic Colorectal Cancer
by: Lucia Scarabel, et al.
Published: (2022-12-01)

HLA-G and Recurrent Pregnancy Loss
by: Greta Barbaro, et al.
Published: (2023-01-01)

HLA-G: A New Immune Checkpoint in Cancer?
by: Daniëlle Krijgsman, et al.
Published: (2020-06-01)

Controlling the immunological crosstalk during conception and pregnancy: HLA-G in reproduction
by: Line eLynge Nilsson, et al.
Published: (2014-05-01)

Expression pattern of HLA-G and HLA-DR molecules on lymphocytes of women and their children with septal congenital heart defects
by: A. V. Shabaldin, et al.
Published: (2024-01-01)

HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
by: Fabio Morandi, et al.
Published: (2022-03-01)

Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection
by: Marta Crespo, et al.
Published: (2021-07-01)

The role of HLA-G molecule and HLA-G gene polymorphisms in tumors, viral hepatitis and parasitic diseases
by: Fabrício César Dias, et al.
Published: (2015-02-01)

Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
by: Siyuan Wang, et al.
Published: (2024-02-01)

Intratumor heterogeneity: A new perspective on colorectal cancer research
by: Zicheng Zheng, et al.
Published: (2020-10-01)

HLA-G Polymorphisms Are Associated with Non-Segmental Vitiligo among Brazilians
by: Luciana Veiga-Castelli, et al.
Published: (2019-09-01)